PDCD1 and neoplasm: In mouse tumor models, COX inhibition by aspirin or celecoxib enhanced the efficacy of anti-PD-1 antibody28, implying that inhibition of the COX-2/PGE2 pathway could be a useful adjuvant to ICI treatment.